TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  Benzinga

Eli Lilly Crushed Novo In Obesity Drug Battle—Trump Now Forces Price Cuts

Benzinga Logo Benzinga By Piero Cingari
Eli Lilly Crushed Novo In Obesity Drug Battle—Trump Now Forces Price Cuts

President Trump announced a major pricing deal with Eli Lilly and Novo Nordisk to make weight-loss drugs more affordable, with Medicare and Medicaid coverage starting in April 2026 and monthly out-of-pocket costs reduced to $50-$350.

Insights
HELFY   neutral

Mentioned as expanding into online grocery space, indicating strategic market positioning


LLY   positive

Stock up 20% year-to-date, strong demand for Zepbound, investor optimism about weight-loss and diabetes treatment pipeline